Selectis Health, Inc.
GBCS- Exchange
- OTC
- Industry
- Real Estate Investment Trusts
- SEC CIK
- 0000727346
No open-market purchases or sales by Selectis Health, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026
- 0
- 13F valueReported value at the end of Q2 2026
- $0
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding GBCS, Q2 2026
No superinvestor reported holding GBCS at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Selectis Health, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 14, 2026 (view filing) | Dec 18, 2025 | 27 daysLate | Baller LanceDirector, 10% Owner | PPurchase | +6.19K | $2.20 | +$13.6K | +13.3%52.8K after | |
| Oct 7, 2022 (view filing) | Oct 6 | 1 day | Baller LanceCEO | PPurchase | +500 | $5.96 | +$2.98K | +0.3%162.0K after | 2 lots |
| Aug 6, 2021 (view filing) | Jul 9 | 28 days | Neuman Clifford L EsqDirector | PPurchase | +100.0K | $0.50 | +$50.0K | +9.3%1.18M after | Amended |
| Jul 13, 2021 (view filing) | Jul 9 | 4 days | Thall BrandonCFO | PPurchase | +20.0K | $0.50 | +$10.0K | New position20.0K after | |
| Jul 13, 2021 (view filing) | Jul 9 | 4 days | Barker Christopher R.PRESIDENT AND COO | PPurchase | +50.0K | $0.50 | +$25.0K | +6.7%801.3K after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Selectis Health, Inc. at the end of Q2 2026; share changes are against Q1 2026.
No institution reported holding GBCS in 13F filings for Q2 2026.